Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.

Biotechnology

Health Care

Universal Cells

Universal Cells' headquarters in Seattle, WA, United States

Michael Dapp

Howard Chang

Brad Miller

Lewis Lanier

Gary Dos Santos

Kyle Knobloch

Paul Messier

Kim Clary

Ryan Davis

Bryan Yi

Mustafa Serdar Tuncali

Sheila Lockwood

Natalie Mostello

Rosa Suen

Nick du

David Fueger

Alejandra Ramirez

Annie Chen

Akina Hoshino

Timothy Turkalo

Rachel Knopp

Borith Kheng

Catiana Holland Cartwright

Katie Lombardo

Cameron Howard

Jackson Stuart

The Research and Development team at Universal Cells focuses on advancing stem cell therapies to combat immune rejection and enable off-the-shelf therapeutic products. They utilize proprietary genome editing techniques to engineer Universal Donor Stem Cells that are HLA-incompatible, ensuring compatibility with all patients. The team is comprised of various levels of researchers and scientists, including associates specializing in gene editing, vector production, cell biology, pharmacology, and in vivo biology, all working collaboratively to innovate and commercialize cutting-edge stem cell solutions.

Research and Development

The Quality Assurance Team at Universal Cells is responsible for ensuring that all stem cell therapies meet stringent quality standards and regulatory requirements. This includes monitoring production processes, conducting detailed audits, and implementing corrective actions to maintain product integrity and compliance. Their work guarantees that Universal Cells' pioneering genome-edited, immune rejection-resistant stem cell therapies are safe, effective, and reliable for patient use.

Quality Assurance Team

The Leadership Team at Universal Cells is responsible for guiding the strategic direction of the company, overseeing research and development efforts, and ensuring the successful commercialization of the company's proprietary stem cell therapies. This team combines executive oversight with scientific expertise to drive innovation, manage key projects, and facilitate collaborations to advance Universal Cells' mission of creating universal donor stem cells.

Leadership Team

The Operations and Facilities team at Universal Cells is responsible for ensuring the efficient and effective functioning of the company's physical infrastructure and laboratory environments. This includes overseeing daily operations, maintaining facilities, coordinating technical requirements, and ensuring compliance with safety and regulatory standards. Their work supports the seamless progression of Universal Cells' groundbreaking stem cell therapies from development through to commercialization.

Operations and Facilities

This department focuses on advancing clinical gene editing strategies and conducting pharmacological studies related to NK biology.

Clinical Research

This department conducts research and development in the field of gene editing technologies.

Gene Editing Research

Universal Cells

Org chart

Teams

Research and Development

Quality Assurance Team

Leadership Team

Operations and Facilities

Clinical Research

Gene Editing Research

Offices

Universal Cells

Org chart

Teams

Research and Development

Quality Assurance Team

Leadership Team

Operations and Facilities

Clinical Research

Gene Editing Research

Offices

Related companies